Camurus Pty Ltd
223 Liverpool Street
Darlinghurst NSW 2010
For general enquiries, you can contact Camurus by email at: [email protected]
Adverse Event Reporting
Reporting suspected adverse reactions after registration of the medicinal product is important. It allows continued monitoring of the benefit-risk balance of the medicinal product.
Healthcare professionals are asked to report suspected adverse reactions and other safety findings including overdose, misuse, abuse, medication errors, loss or lack of effect, pregnancy and lactation exposure, and any unexpected therapeutic benefit to:
Please note that Camurus Drug Safety may contact you to follow up if clarification of the spontaneous report is required.
Healthcare professionals are also encouraged to report any adverse events directly to the Therapeutic Goods Administration (TGA) at www.tga.gov.au/reporting-problems
Product complaints are to be reported to [email protected]